Table 5. Comparison of G × G interaction frequencies between the normal and hyperlipidemia groups [n (frequency)].

No

G × G inteaction

Hyperlipidemia

Normal

x2

P

OR (95%CI)

A

B

C

D

E

F

G

H

I

J

K

L

H1

C

C

C

A

G

C

A

T

C

G

A

T

440.78(0.177)

422.58(0.169)

1.961

0.021

0.9 (0.8-1.1)

H2

T

C

C

A

G

C

A

T

C

G

A

T

219.96(0.088)

251.06(0.101)

9.170

0.002

0.6 (0.6-0.9)

H3

T

T

C

A

G

C

A

T

C

G

A

T

162.55(0.065)

99.41(0.040)

9.610

0.002

1.5 (1.2-2.0)

H4

T

T

T

A

G

C

A

T

C

G

A

T

119.10(0.048)

91.43(0.037)

1.178

0.278

1.2 (0.9-1.6)

H5

C

C

C

A

G

C

A

T

C

A

G

C

109.61(0.044)

46.95(0.019)

19.385

E-005

2.2 (0.9-1.6)

H6

C

C

C

A

G

C

G

C

G

A

G

C

55.83(0.022)

87.32(0.035)

11.910

6E-004

0.6 (1.5-3.0)

H7

T

T

T

A

G

C

G

C

C

G

A

T

95.07(0.038)

33.78(0.014)

23.537

E-006

2.6 (1.8-3.9)

H8

T

T

T

A

G

C

G

C

C

A

G

C

42.20(0.017)

76.13(0.031)

14.956

E-004

0.5 (0.3-0.7)

H9

T

T

T

A

G

C

A

T

C

A

G

C

16.45(0.007)

100.45(0.040)

74.461

7E-018

0.1 (0.1-0.2)

A: NCAN rs2238675 C>T. B: NCAN rs2228603 C>T. C: TM6SF2 rs58542926 C>T. D: TM6SF2 rs735273 A>G. E: CILP2 rs16996148 G>T. F: CILP2 rs17216525 C>T. G: PBX4 rs12610185 G>A. H: SUGP1 rs10401969 T>C. I: MAU2 rs73001065 G>C. J: MAU2 rs8102280 G>A. K: MAU2 rs150268548 G>A. L: MAU2 rs968525 C>T. NCAN: the neurocan gene. TM6SF2: the transmembrane 6 superfamily member 2 gene. CILP2: the cartilage intermediate layer protein 2 gene. PBX4: the PBX homeobox 4 gene. SUGP1: the SURP and G-patch domain containing 1 gene. MAU2: the MAU2 sister chromatid cohesion factor gene.